Suppr超能文献

经皮左心耳封堵术治疗心房颤动后与器械相关的血栓形成。

Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation.

机构信息

Trousseau University Hospital, Faculty of Medicine, François Rabelais University, Tours, France.

Trousseau University Hospital, Faculty of Medicine, François Rabelais University, Tours, France.

出版信息

J Am Coll Cardiol. 2018 Apr 10;71(14):1528-1536. doi: 10.1016/j.jacc.2018.01.076.

Abstract

BACKGROUND

Transcatheter left atrial appendage (LAA) occlusion is an alternative strategy for stroke prevention in patients with atrial fibrillation (AF).

OBJECTIVES

This study sought to determine the incidence, predictors, and prognosis of thrombus formation on devices in patients with AF who were treated with LAA closure.

METHODS

The study retrospectively analyzed data from patients treated with 2 LAA closure devices seen in 8 centers in France from February 2012 to January 2017.

RESULTS

A total of 469 consecutive patients with AF underwent LAA closure (272 Watchman devices [Atritech, Boston Scientific, Natick, Massachusetts] and 197 Amplatzer devices [St. Jude Medical, Minneapolis, Minnesota]). Mean follow-up was 13 ± 13 months, during which 339 (72.3%) patients underwent LAA imaging at least once. There were 98 major adverse events (26 thrombi on devices, 19 ischemic strokes, 2 transient ischemic attacks, 18 major hemorrhages, 33 deaths) recorded in 89 patients. The incidence of device-related thrombus in patients with LAA imaging was 7.2% per year. Older age (hazard ratio [HR]: 1.07 per 1-year increase; 95% confidence interval [CI]: 1.01 to 1.14; p = 0.02) and history of stroke (HR: 3.68; 95% CI: 1.17 to 11.62; p = 0.03) were predictors of thrombus formation on the devices, whereas dual antiplatelet therapy (HR: 0.10; 95% CI: 0.01 to 0.76; p = 0.03) and oral anticoagulation at discharge (HR: 0.26; 95% CI: 0.09 to 0.77; p = 0.02) were protective factors. Thrombus on the device (HR: 4.39; 95% CI: 1.05 to 18.43; p = 0.04) and vascular disease (HR: 5.03; 95% CI: 1.39 to 18.23; p = 0.01) were independent predictors of ischemic strokes and transient ischemic attacks during follow-up.

CONCLUSIONS

Thrombus formation on the device is not uncommon in patients with AF who are treated by LAA closure. Such events are strongly associated with a higher risk of ischemic stroke during follow-up. (REgistry on Real-Life EXperience With Left Atrial Appendage Occlusion [RELEXAO]; NCT03279406).

摘要

背景

经导管左心耳(LAA)封堵术是预防房颤(AF)患者卒中的一种替代策略。

目的

本研究旨在确定接受 LAA 封堵治疗的 AF 患者中,器械上血栓形成的发生率、预测因素和预后。

方法

该研究回顾性分析了 2012 年 2 月至 2017 年 1 月法国 8 个中心使用 2 种 LAA 封堵装置治疗的患者数据。

结果

共 469 例连续 AF 患者接受了 LAA 封堵术(272 个 Watchman 装置[雅培公司,波士顿科学公司,马萨诸塞州纳提克]和 197 个 Amplatzer 装置[圣犹达医疗公司,明尼苏达州明尼阿波利斯])。平均随访 13±13 个月,在此期间,339 例(72.3%)患者至少进行了一次 LAA 影像学检查。89 例患者共记录了 98 例主要不良事件(26 例器械相关血栓形成、19 例缺血性卒、2 例短暂性脑缺血发作、18 例大出血、33 例死亡)。LAA 影像学检查的患者中,器械相关血栓形成的发生率为每年 7.2%。年龄较大(风险比[HR]:每增加 1 岁为 1.07;95%置信区间[CI]:1.01 至 1.14;p=0.02)和既往卒中史(HR:3.68;95%CI:1.17 至 11.62;p=0.03)是器械上血栓形成的预测因素,而双联抗血小板治疗(HR:0.10;95%CI:0.01 至 0.76;p=0.03)和出院时的口服抗凝治疗(HR:0.26;95%CI:0.09 至 0.77;p=0.02)是保护因素。器械上血栓形成(HR:4.39;95%CI:1.05 至 18.43;p=0.04)和血管疾病(HR:5.03;95%CI:1.39 至 18.23;p=0.01)是随访期间缺血性卒中和短暂性脑缺血发作的独立预测因素。

结论

在接受 LAA 封堵治疗的 AF 患者中,器械上血栓形成并不罕见。此类事件与随访期间更高的缺血性卒风险密切相关。(真实世界左心耳封堵术经验登记研究[RELEXAO];NCT03279406)。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验